Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2
Por um escritor misterioso
Descrição
KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents
PDF) Advances in CXCR7 modulators
Immune regulation by atypical chemokine receptors
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
KR100837019B1 - 3-4-heteroarylcyclohexylaminocyclopentanecarboxamides as modulators of chemokine receptors - Google Patents
Pharmaceuticals, Free Full-Text
Targeting lung inflammation: novel therapies for the treatment of COPD. - Abstract - Europe PMC
Malcolm MacCoss's research works Merck & Co., Whitehouse Station (MSD) and other places
CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV. - Abstract - Europe PMC
Small molecules in the treatment of COVID-19
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties - ScienceDirect
Novel, Orally Bioavailable γ-Aminoamide CC Chemokine Receptor 2 (CCR2) Antagonists
de
por adulto (o preço varia de acordo com o tamanho do grupo)
